Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity

Biochemistry
V S StollE F Pai

Abstract

Trypanosoma and Leishmania, pathogens responsible for diseases such as African sleeping sickness, Chagas' heart disease, or Oriental sore, are two of the very few genera that do not use the ubiquitous glutathione/glutathione reductase system to keep a stable cellular redox balance. Instead, they rely on trypanothione and trypanothione reductase to protect them from oxidative stress. Trypanothione reductase (TR) and the corresponding host enzyme, human red blood cell glutathione reductase (GR), belong to the same flavoprotein family. Despite their closely related three-dimensional structures and although their natural substrates share the common structural glutathione core, the two enzymes are mutually exclusive with respect to their disulfide substrates. This makes the parasite enzyme a potential target for antitrypanosomal drug design. While a large body of structural data on GR complexes is available, information on TR-ligand interactions is very limited. When the two amino acid changes Ala34Glu and Arg37Trp are introduced into human GR, the resulting mutant enzyme (GRTR) prefers trypanothione 700-fold over its original substrate, effectively converting a GR into a TR [Bradley, M., Bücheler, U. S., & Walsh, C. T. (1991) Bioch...Continue Reading

References

Aug 1, 1976·European Journal of Biochemistry·D J Worthington, M A Rosemeyer
Jun 1, 1975·FEBS Letters·G E Schult, H Zappe
Jan 1, 1992·Annual Review of Microbiology·A H Fairlamb, A Cerami
Sep 5, 1992·Journal of Molecular Biology·W N HunterA H Fairlamb
Jan 2, 1989·European Journal of Biochemistry·P A KarplusG E Schulz
Jun 5, 1987·Journal of Molecular Biology·P A Karplus, G E Schulz
Jan 1, 1983·Annual Review of Biochemistry·A Meister, M E Anderson

❮ Previous
Next ❯

Citations

Nov 24, 1999·Free Radical Biology & Medicine·L FlohéP Steinert
Nov 24, 1999·Free Radical Biology & Medicine·H Sies
Oct 17, 2002·Trends in Parasitology·Robert P HirtGraham H Coombs
Apr 24, 2002·Antioxidants & Redox Signaling·Daniel J Steenkamp
Mar 8, 2011·Molecular Neurodegeneration·Shengchun LiuWeihong Song
May 20, 2003·Biological Chemistry·Shane R Wilkinson, John M Kelly
Jul 1, 2008·Free Radical Biology & Medicine·Florencia IrigoínRafael Radi
Feb 17, 2009·Structure·Akira R Kinjo, Haruki Nakamura
Feb 18, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Alberto Guevara-FloresIrene Patricia Del Arenal
Dec 26, 2001·The Journal of Biological Chemistry·Yongting WangVictor L Davidson
Apr 25, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Theo BattistaAnnarita Fiorillo
Feb 20, 2019·Frontiers in Cellular and Infection Microbiology·Anurag KumarShailza Singh
Nov 17, 2001·Chemical Reviews·T M Penning, J M Jez
Nov 14, 2020·Journal of Biomolecular Structure & Dynamics·Priscila Goes CamargoFernando Macedo
Jul 22, 2005·Journal of Medicinal Chemistry·Svea MeieringR Luise Krauth-Siegel

❮ Previous
Next ❯

Related Concepts

Related Feeds

BioHub - Researcher Network

The Chan-Zuckerberg Biohub aims to support the fundamental research and develop the technologies that will enable physicians to cure, prevent, or manage all diseases in our childrens' lifetimes. The CZ Biohub brings together researchers from UC Berkeley, Stanford, and UCSF. Find the latest research from the CZ Biohub researcher network here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.